GAMMAGARD

This brand name is authorized in Austria, Canada, Spain, Finland, France, Ireland, Japan, Netherlands, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug GAMMAGARD contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02231470, 02231471, 02279444
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60717, 60718
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 559161, 559187
Country: FR	Base de données publique des médicaments	Identifier(s): 68399068
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 47641, 47654
Country: JP	医薬品医療機器総合機構	Identifier(s): 6343420X2029
Country: NL	Z-Index G-Standaard	Identifier(s): 13897152, 13897160
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 41084, 41092
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100193036
Country: SG	Health Sciences Authority	Identifier(s): 08493P
Country: US	FDA, National Drug Code	Identifier(s): 0944-2700